- Home
- NUWE vs SHPH Comparison
NUWE vs SHPH Comparison
Compare NUWE & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- SHPH
- Stock Information
- Founded
- NUWE 1999
- SHPH 2012
- Country
- NUWE United States
- SHPH United States
- Employees
- NUWE N/A
- SHPH N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- SHPH Health Care
- Exchange
- NUWE Nasdaq
- SHPH Nasdaq
- Market Cap
- NUWE 2.9M
- SHPH 3.2M
- IPO Year
- NUWE N/A
- SHPH 2022
- Fundamental
- Price
- NUWE $2.46
- SHPH $1.34
- Analyst Decision
- NUWE
- SHPH
- Analyst Count
- NUWE 0
- SHPH 0
- Target Price
- NUWE N/A
- SHPH N/A
- AVG Volume (30 Days)
- NUWE 125.1K
- SHPH 518.8K
- Earning Date
- NUWE 11-12-2025
- SHPH 11-13-2025
- Dividend Yield
- NUWE N/A
- SHPH N/A
- EPS Growth
- NUWE N/A
- SHPH N/A
- EPS
- NUWE N/A
- SHPH N/A
- Revenue
- NUWE $8,167,999.00
- SHPH N/A
- Revenue This Year
- NUWE $6.53
- SHPH N/A
- Revenue Next Year
- NUWE $51.63
- SHPH N/A
- P/E Ratio
- NUWE N/A
- SHPH N/A
- Revenue Growth
- NUWE N/A
- SHPH N/A
- 52 Week Low
- NUWE $2.02
- SHPH $1.26
- 52 Week High
- NUWE $70.14
- SHPH $25.25
- Technical
- Relative Strength Index (RSI)
- NUWE 43.44
- SHPH 22.25
- Support Level
- NUWE $2.02
- SHPH $1.31
- Resistance Level
- NUWE $2.71
- SHPH $2.11
- Average True Range (ATR)
- NUWE 0.20
- SHPH 0.24
- MACD
- NUWE 0.01
- SHPH -0.07
- Stochastic Oscillator
- NUWE 47.25
- SHPH 7.30
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.